These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 35771983)

  • 1. Lymphatic vessels in cancer.
    Dieterich LC; Tacconi C; Ducoli L; Detmar M
    Physiol Rev; 2022 Oct; 102(4):1837-1879. PubMed ID: 35771983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic Vessels in Tumor Dissemination versus Immunotherapy.
    Vaahtomeri K; Alitalo K
    Cancer Res; 2020 Sep; 80(17):3463-3465. PubMed ID: 32605997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor metastasis and the lymphatic vasculature.
    Sleeman JP; Thiele W
    Int J Cancer; 2009 Dec; 125(12):2747-56. PubMed ID: 19569051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.
    Maisel K; Sasso MS; Potin L; Swartz MA
    Adv Drug Deliv Rev; 2017 May; 114():43-59. PubMed ID: 28694027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic vessel activation in cancer.
    Das S; Skobe M
    Ann N Y Acad Sci; 2008; 1131():235-41. PubMed ID: 18519976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lymphangiogenesis in lymphatic tumour spread of urological cancers.
    Bolenz C; Fernández MI; Tilki D; Herrmann E; Heinzelbecker J; Ergün S; Ströbel P; Reich O; Michel MS; Trojan L
    BJU Int; 2009 Sep; 104(5):592-7. PubMed ID: 19594740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple roles of lymphatic vessels in tumor progression.
    Ma Q; Dieterich LC; Detmar M
    Curr Opin Immunol; 2018 Aug; 53():7-12. PubMed ID: 29605736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory roles of lymphatic vessels in cancer progression.
    Swartz MA
    Cancer Immunol Res; 2014 Aug; 2(8):701-7. PubMed ID: 25092811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's disease.
    Hirakawa S; Detmar M; Kerjaschki D; Nagamatsu S; Matsuo K; Tanemura A; Kamata N; Higashikawa K; Okazaki H; Kameda K; Nishida-Fukuda H; Mori H; Hanakawa Y; Sayama K; Shirakata Y; Tohyama M; Tokumaru S; Katayama I; Hashimoto K
    Am J Pathol; 2009 Nov; 175(5):2235-48. PubMed ID: 19815713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological and anatomical basis of lymphatic transit of cancer cells and role of the lymphatic system: a review of published literature.
    Matanes E; Gotlieb WH
    Chin Clin Oncol; 2021 Apr; 10(2):14. PubMed ID: 33548982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing Roles of Vascular Endothelial Growth Factor C in Metastatic Dissemination and Resistance to Radio/Chemotherapy: Discussion of Mechanisms and Therapeutic Strategies.
    Montemagno C; Luciano F; Pagès G
    Methods Mol Biol; 2022; 2475():1-23. PubMed ID: 35451746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and Clinical Significance of Tumor Lymphatic Invasion.
    Fujimoto N; Dieterich LC
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
    Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
    Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NADPH oxidase 4 attenuates lymphangiogenesis and tumor metastasis in breast cancer.
    Wang X; Liu Z; Sun J; Song X; Bian M; Wang F; Yan F; Yu Z
    FASEB J; 2021 Apr; 35(4):e21531. PubMed ID: 33769605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes.
    Leary N; Walser S; He Y; Cousin N; Pereira P; Gallo A; Collado-Diaz V; Halin C; Garcia-Silva S; Peinado H; Dieterich LC
    J Extracell Vesicles; 2022 Feb; 11(2):e12197. PubMed ID: 35188342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of tumor cells and lymphatic vessels in cancer progression.
    Alitalo A; Detmar M
    Oncogene; 2012 Oct; 31(42):4499-508. PubMed ID: 22179834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lymphatic vasculature in disease.
    Alitalo K
    Nat Med; 2011 Nov; 17(11):1371-80. PubMed ID: 22064427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.